Cite
Maggiore C, Vazquez JA, Guervil DJ, et al. Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit. Ther Clin Risk Manag. 2015;11:557-63doi: 10.2147/TCRM.S75191.
Maggiore, C., Vazquez, J. A., Guervil, D. J., Ramani, A., Jandourek, A., Cole, P., & Friedland, H. D. (2015). Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit. Therapeutics and clinical risk management, 11557-63. https://doi.org/10.2147/TCRM.S75191
Maggiore, Christy, et al. "Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit." Therapeutics and clinical risk management vol. 11 (2015): 557-63. doi: https://doi.org/10.2147/TCRM.S75191
Maggiore C, Vazquez JA, Guervil DJ, Ramani A, Jandourek A, Cole P, Friedland HD. Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit. Ther Clin Risk Manag. 2015 Apr 02;11:557-63. doi: 10.2147/TCRM.S75191. eCollection 2015. PMID: 25897240; PMCID: PMC4397928.
Copy
Download .nbib